Rockwell Medical (RMTI) Other Non-Current Assets (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Other Non-Current Assets came in at $556000.0 in Q1 2026, up 6.72% YoY from $521000.0 in Q1 2025, and little changed on a QoQ basis from $556000.0 in Q4 2025.
Rockwell Medical (RMTI) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Other Non-Current Assets data on file, last reported at $556000.0 in Q1 2026.
- Quarterly Other Non-Current Assets rose 6.72% year-over-year to $556000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $556000.0 (up 6.72% YoY) and the FY2025 annual result came in at $556000.0, up 5.3% from the prior year.
- Other Non-Current Assets steadied at $556000.0 in Q1 2026, from $556000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $618000.0 in Q1 2022 to a low of $509000.0 in Q2 2022.
- A 5-year average of $540058.8 and a median of $527000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets decreased 28.4% — and 2026, when it advanced 6.72%.
- Tracing RMTI's Other Non-Current Assets over 5 years: stood at $523000.0 in 2022, then rose by 0.76% to $527000.0 in 2023, then increased by 0.19% to $528000.0 in 2024, then advanced by 5.3% to $556000.0 in 2025, then changed by 0.0% to $556000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $556000.0 (Q1 2026), $556000.0 (Q4 2025), and $561000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 13.00 Mn |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | 556,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 556,000.00 |
| Mar 31, 2026 | 556,000.00 |
| Dec 31, 2025 | 556,000.00 |
| Sep 30, 2025 | 561,000.00 |
| Jun 30, 2025 | 561,000.00 |
| Mar 31, 2025 | 521,000.00 |
| Dec 31, 2024 | 528,000.00 |
| Sep 30, 2024 | 548,000.00 |
| Jun 30, 2024 | 548,000.00 |
| Mar 31, 2024 | 527,000.00 |
| Dec 31, 2023 | 527,000.00 |
| Sep 30, 2023 | 527,000.00 |
| Jun 30, 2023 | 527,000.00 |
| Mar 31, 2023 | 522,000.00 |
| Dec 31, 2022 | 523,000.00 |
| Sep 30, 2022 | 522,000.00 |
| Jun 30, 2022 | 509,000.00 |
| Mar 31, 2022 | 618,000.00 |
| Dec 31, 2021 | 619,000.00 |
| Sep 30, 2021 | 729,000.00 |